| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-07 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.2 | 4e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-07 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.23 | 5e-07 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.18 | 5e-07 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.21 | 9e-07 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.19 | 9e-07 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.28 | 1e-06 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.21 | 2e-06 |